Correction: Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis - Quiz - MDSpire

Targeting Sodium+/taurocholate Cotransporting Polypeptide for the Treatment of Liver Fibrosis

August 1, 2026

Gut

Share

Original Source(s)

Gut

Correction: Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis

August 1, 2026

Related Content

Gut

GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair

Gut

Correction: Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

August 1, 2026

Surgical Endoscopy

Predictors of conversion in laparoscopic Crohn’s surgery: a retrospective analysis of a tertiary cohort